TET2 and acute myeloid leukemia: Dysfunction of TET2 is well-proved to be associated with acute myelocytic leukemia (AML), myelodysplastic syndromes (MDS) and other myeloid disorders (Delhommeau et al., 2009; Langemeijer et al., 2009).